Furthermore, GHRH antagonists have been shown to enhance chemotherapy efficacy in various cancers, including lung cancer, pleural mesothelioma, and pituitary adenomas [13,15,20,22,23,33,34]. Here, GHRH is linked to pituitary gland adenoma.